This case series evaluates the clinical response, safety profile, and time to improvement for high-dose oral vitamin D in patients with toxic erythema of chemotherapy and acute radiation dermatitis.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Enfortumab Vedotin−Induced Cutaneous Toxic Effects and Survival in Urothelial Carcinoma | 0 | 6.29 | 01-09-2026 |
| 2 | Tuberculosis-Related Outcomes in Dermatologic Patients Receiving Systemic Therapy | 0 | 10.27 | 01-09-2026 |
| 3 | Melanoma Prevention Among Children of Melanoma Survivors | 0 | 8.06 | 07-10-2026 |
| 4 | Golidocitinib for Folliculotropic Mycosis Fungoides | 0 | 15.88 | 01-09-2026 |
| 5 | Golimumab in Treatment-Refractory Hidradenitis Suppurativa | 0 | 7.71 | 01-09-2026 |
| 6 | BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus | 0 | 28.92 | 30-09-2026 |
| 7 | Lumpectomy Margins and Local Recurrence in DCIS | 0 | 8.55 | 01-09-2026 |
| 8 | Longitudinal Growth in Children With Epidermal Differentiation Disorders | 0 | 8.23 | 30-09-2026 |
| 9 | Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma | 0 | 4.08 | 01-09-2026 |
| 10 | Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer | 0 | 6.4 | 01-09-2026 |